Ibrexafungerp


CAS No. : 1207753-03-4

(Synonyms: MK 3118; SCY-078)

1207753-03-4
Price and Availability of CAS No. : 1207753-03-4
Size Price Stock
1mg $220 In-stock
5mg $570 In-stock
10mg $920 In-stock
25mg $1850 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-107126
M.Wt: 730.03
Formula: C44H67N5O4
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1207753-03-4 :

Ibrexafungerp (MK 3118) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections[1]. In Vitro: Ibrexafungerp leads to fungicidal activity against various Candida spp., with MIC of 0.5 µg/mL[2].
Ibrexafungerp is effective against C. albicans, C. krusei, C. parapsilosis with MICs of 0.06, 0.5, 0.25  µg/mL[5].
In Vivo: Ibrexafungerp (p.o., 10 mg/kg) is effective against C. auris in an guinea pig cutaneous infection model[4].
Ibrexafungerp (p.o., mouse 1 mg/kg, rat 5 mg/kg and dog 5 mg/kg) exhibits oral bioavailability (mouse 51%, rat 45%, dog 35%)[3].
Ibrexafungerp (i.v., mouse 1 mg/kg, rat 5 mg/kg and dog 5 mg/kg) exhibits moderate half-lives (mouse 5.5, rat 8.7 and, dog 9.3 h) due to high plasma clearance (0.68, 0.44, and 0.45 L/h/kg respectively)[3].

Your information is safe with us.